We are live on ! Find out more
TAM

TFG Asset Management Portfolio holdings

AUM $635M Turnover 36.96%
1-Year Est. Return 28.07%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+28.07%
3 Year Est. Return
+72.07%
5 Year Est. Return
+87.41%
10 Year Est. Return
+132.97%
AUM
$391M
AUM Growth
+$36.9M
Cap. Flow
-$91M
Cap. Flow %
-23.25%
Top 10 Hldgs %
83.05%
Holding
29
New
5
Increased
6
Reduced
4
Closed
2
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1 year

Top Buys

Rank Stock Value
1
KROS icon
Keros Therapeutics
KROS
+$5.35M
2
INFA icon
Informatica
INFA
+$5.24M
3
CLDX icon
Celldex Therapeutics
CLDX
+$5.22M
4
AXSM icon
Axsome Therapeutics
AXSM
+$3.79M
5
ANNX icon
Annexon
ANNX
+$3.79M

Top Sells

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$18.8M
2
BALY icon
Bally's
BALY
+$4.8M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.68M
4
TECK icon
Teck Resources
TECK
+$893K
5
NE.WS icon
Noble Corporation PLC Tranche 1 Warrants
NE.WS
+$754K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.93%
2 Technology 36%
3 Healthcare 12.16%
4 Energy 9.61%
5 Materials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PATH icon
1
UiPath
PATH
$7.15B
$88.3M 22.57%
6,950,000
– –
2022 Q1
11 quarters
HYG icon
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$78M 19.93%
991,800
+531,800
+116% +$42.2M
2024 Q1
3 quarters
KGEI icon
3
Kolibri Global Energy
KGEI
$238M
$37.6M 9.61%
7,070,568
– –
2023 Q4
4 quarters
AUTL icon
4
Autolus Therapeutics
AUTL
$458M
$19.4M 4.95%
8,250,000
+250,000
+3% +$845K
2018 Q2
26 quarters
CXM icon
5
Sprinklr
CXM
$1.36B
$18.6M 4.75%
2,200,000
– –
2022 Q1
11 quarters
INFA icon
6
DELISTED
Informatica
INFA
$15.6M 3.97%
600,000
+200,000
+50% +$5.24M
2024 Q3
1 quarter
LYFT icon
7
Lyft
LYFT
$6.5B
$12.9M 3.3%
1,000,000
– –
2021 Q4
12 quarters
TARS icon
8
Tarsus Pharmaceuticals
TARS
$3.32B
$11.1M 2.83%
200,000
-414,117
-67% -$18.8M
2023 Q2
6 quarters
ANNX icon
9
Annexon
ANNX
$682M
$7.18M 1.83%
1,400,000
+615,645
+78% +$3.79M
2024 Q2
2 quarters
HYG icon
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$7.1M 1.81%
90,327
-21,198
-19% -$1.68M
2022 Q4
8 quarters
CLDX icon
11
Celldex Therapeutics
CLDX
$2.27B
$4.85M 1.24%
+192,000
New +$5.22M
2024 Q4
0 quarters
BBAI icon
12
BigBear.ai
BBAI
$1.12B
$4M 1.02%
+900,000
New +$2.04M
2024 Q4
0 quarters
MPT icon
13
CALL
Medical Properties Trust
MPT
$1.86B
$3.56M 0.91%
902,500
+260,000
+40% +$1.16M
2024 Q2
2 quarters
AXSM icon
14
Axsome Therapeutics
AXSM
$8.47B
$3.49M 0.89%
+41,250
New +$3.79M
2024 Q4
0 quarters
KROS icon
15
Keros Therapeutics
KROS
$220M
$1.63M 0.42%
+103,000
New +$5.35M
2024 Q4
0 quarters
SNOW icon
16
Snowflake
SNOW
$118B
$1.54M 0.39%
10,000
– –
2021 Q4
12 quarters
HBM icon
17
Hudbay
HBM
$10.8B
$470K 0.12%
58,000
-23,000
-28% -$206K
2024 Q3
1 quarter
BVN icon
18
Compañía de Minas Buenaventura
BVN
$7.91B
$426K 0.11%
+37,000
New +$474K
2024 Q4
0 quarters
TECK icon
19
Teck Resources
TECK
$32.3B
$258K 0.07%
6,368
-19,119
-75% -$893K
2022 Q1
11 quarters
DSX.WS icon
20
Diana Shipping Inc Warrants exp 2026
DSX.WS
$5.67M
$33.5K 0.01%
301,800
+1,500
+0.5% +$324
2024 Q1
3 quarters
SONDW icon
21
DELISTED
Sonder Holdings Inc Warrants
SONDW
$121 ﹤0.01%
18,898
– –
2021 Q2
14 quarters
BALY icon
22
Bally's
BALY
$677M
– –
-278,493
Closed -$4.8M –
NE.WS icon
23
Noble Corporation PLC Tranche 1 Warrants
NE.WS
– –
-43,000
Closed -$754K –

Similar funds

GRR
Golden Reserve Retirement Dublin, Ohio $635M AUM 25.04% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $635M AUM 14.36% 1-Year Est. Return
MPIA
Mountain Pacific Investment Advisers Boise, Idaho $635M AUM 26.7% 1-Year Est. Return
AFG
Altiora Financial Group Lebanon, Ohio $634M AUM 13.93% 1-Year Est. Return
MCM
Maytus Capital Management New York $636M AUM 131.32% 1-Year Est. Return
BAM
BOCHK Asset Management Hong Kong $634M AUM 64.99% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $637M AUM 25.11% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $637M AUM 2.87% 1-Year Est. Return

TFG Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, TFG Asset Management held 29 positions worth $391M, up 10% from $355M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

TFG Asset Management withdrew a net $91M in Q4 2024, closing 2 positions and reducing 4 holdings. Its most notable exit was Bally's, an estimated $4.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.

Against the trend, TFG Asset Management opened a new position in Keros Therapeutics worth $1.63M.

  • TFG Asset Management's largest Q4 2024 buy was Keros Therapeutics: 103,000 shares worth $1.63M.
  • TFG Asset Management added most to Informatica in Q4 2024, an estimated $5.24M increase.
  • TFG Asset Management's biggest Q4 2024 reduction was Tarsus Pharmaceuticals, cutting an estimated $18.8M.
  • TFG Asset Management fully exited Bally's in Q4 2024, selling an estimated $4.8M.
  • TFG Asset Management's ten largest holdings make up 83% of its $391M portfolio in Q4 2024.
  • TFG Asset Management opened 5 new positions and closed 2 in Q4 2024.
  • TFG Asset Management's portfolio value rose 10% quarter-over-quarter to $391M.

Based on TFG Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.